{"transactions":[{"id":2821997,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-03-02T17:30:05.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":226,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8583,"source":{"system":"sec-edgar","filing":"0001225208-21-004296","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000122520821004296/doc4.xml","form_type":"4"}},{"id":2961440,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-12-02T17:33:45.000Z","date":"2020-11-30","kind":"grant","acquired":true,"shares":227,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8357,"source":{"system":"sec-edgar","filing":"0001225208-20-014156","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000122520820014156/doc4.xml","form_type":"4"}},{"id":3041649,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-09-02T17:37:48.000Z","date":"2020-08-31","kind":"grant","acquired":true,"shares":267,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8130,"source":{"system":"sec-edgar","filing":"0001225208-20-011224","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000122520820011224/doc4.xml","form_type":"4"}},{"id":3110999,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-15T22:43:30.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":273,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16234,"source":{"system":"sec-edgar","filing":"0000927066-20-000144","document":"wf-form4_159226099264163.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/927066/000092706620000144/wf-form4_159226099264163.xml","form_type":"4"}},{"id":3115231,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Appreciation Rights","published_at":"2020-06-10T22:21:36.000Z","date":"2020-06-08","kind":"exercise","acquired":false,"shares":4662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Appreciation Rights were granted on June 16, 2015, and 100% vested on June 16, 2016."}],"balance_after":0,"derivative":{"exercise_price":81.51,"exercise_date":"2016-06-16","expiration_date":"2020-06-16","underlying":"Common Stock","underlying_shares":4662},"source":{"system":"sec-edgar","filing":"0000927066-20-000133","document":"wf-form4_159182767735962.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/927066/000092706620000133/wf-form4_159182767735962.xml","form_type":"4"}},{"id":3115230,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-10T22:21:36.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":357,"price":86.7885,"value":30983.4945,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of $86.7885. The range of prices for the sale of these shares was $86.7701 - $86.8250 rounded to the nearest ten-thousandths. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":15961,"source":{"system":"sec-edgar","filing":"0000927066-20-000133","document":"wf-form4_159182767735962.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/927066/000092706620000133/wf-form4_159182767735962.xml","form_type":"4"}},{"id":3115229,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-10T22:21:36.000Z","date":"2020-06-08","kind":"disposition_to_issuer","acquired":false,"shares":4305,"price":88.28,"value":380045.4,"ownership":{"direct":true},"balance_after":16318,"source":{"system":"sec-edgar","filing":"0000927066-20-000133","document":"wf-form4_159182767735962.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/927066/000092706620000133/wf-form4_159182767735962.xml","form_type":"4"}},{"id":3115228,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-10T22:21:36.000Z","date":"2020-06-08","kind":"exercise","acquired":true,"shares":4662,"price":81.51,"value":379999.62,"ownership":{"direct":true},"balance_after":20623,"source":{"system":"sec-edgar","filing":"0000927066-20-000133","document":"wf-form4_159182767735962.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/927066/000092706620000133/wf-form4_159182767735962.xml","form_type":"4"}},{"id":3127716,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-06-02T17:15:48.000Z","date":"2020-05-29","kind":"grant","acquired":true,"shares":240,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7863,"source":{"system":"sec-edgar","filing":"0001225208-20-008490","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000122520820008490/doc4.xml","form_type":"4"}},{"id":3143747,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T01:18:29.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":599,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15961,"source":{"system":"sec-edgar","filing":"0000927066-20-000104","document":"wf-form4_158993749152852.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/927066/000092706620000104/wf-form4_158993749152852.xml","form_type":"4"}},{"id":3158446,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-05-07T17:09:25.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":2819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were executed in anticipation of the option expiration date of May 9, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options were granted on May 9, 2013 and vested in three equal installments on May 1, 2014, May 1, 2015 and May 1, 2016."}],"balance_after":0,"derivative":{"exercise_price":128.2383,"expiration_date":"2020-05-09","underlying":"Common Stock, $.01 Par Value","underlying_shares":2819},"source":{"system":"sec-edgar","filing":"0001225208-20-007213","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000122520820007213/doc4.xml","form_type":"4"}},{"id":3158445,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-05-07T17:09:25.000Z","date":"2020-05-05","kind":"sale","acquired":false,"shares":2819,"price":192.07,"value":541445.33,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were executed in anticipation of the option expiration date of May 9, 2020."}],"balance_after":7623,"source":{"system":"sec-edgar","filing":"0001225208-20-007213","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000122520820007213/doc4.xml","form_type":"4"}},{"id":3158444,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-05-07T17:09:25.000Z","date":"2020-05-05","kind":"exercise","acquired":true,"shares":2819,"price":128.2383,"value":361503.7677,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were executed in anticipation of the option expiration date of May 9, 2020."}],"balance_after":10442,"source":{"system":"sec-edgar","filing":"0001225208-20-007213","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000122520820007213/doc4.xml","form_type":"4"}},{"id":3206941,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-17T23:55:20.000Z","date":"2020-03-15","kind":"grant","acquired":true,"shares":625,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15362,"source":{"system":"sec-edgar","filing":"0000927066-20-000046","document":"wf-form4_158448930274722.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/927066/000092706620000046/wf-form4_158448930274722.xml","form_type":"4"}},{"id":3234229,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-03-03T17:07:07.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":259,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7623,"source":{"system":"sec-edgar","filing":"0001225208-20-004186","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000122520820004186/doc4.xml","form_type":"4"}},{"id":3356126,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-12-02T19:41:59.000Z","date":"2019-11-29","kind":"grant","acquired":true,"shares":237,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7364,"source":{"system":"sec-edgar","filing":"0001225208-19-015094","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000122520819015094/doc4.xml","form_type":"4"}},{"id":3366687,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-19T23:24:12.000Z","date":"2019-11-15","kind":"grant","acquired":true,"shares":671,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14737,"source":{"system":"sec-edgar","filing":"0000927066-19-000190","document":"wf-form4_157420583621511.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/927066/000092706619000190/wf-form4_157420583621511.xml","form_type":"4"}},{"id":3423785,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-09-04T17:34:36.000Z","date":"2019-08-30","kind":"grant","acquired":true,"shares":308,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7127,"source":{"system":"sec-edgar","filing":"0001225208-19-012171","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000122520819012171/doc4.xml","form_type":"4"}},{"id":3436701,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-16T22:20:46.000Z","date":"2019-08-15","kind":"grant","acquired":true,"shares":814,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14066,"source":{"system":"sec-edgar","filing":"0000927066-19-000155","document":"wf-form4_156599403140555.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/927066/000092706619000155/wf-form4_156599403140555.xml","form_type":"4"}},{"id":3505316,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-06-03T18:23:37.000Z","date":"2019-05-30","kind":"exercise","acquired":false,"shares":3298,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents options that were automatically exercised immediately prior to their expiration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Stock options previously awarded pursuant to Express Scripts, Inc. 2011 Long-Term Incentive Plan.  Options vested in three equal annual installments on May 1, 2013, May 1, 2014, and May 1, 2015."}],"balance_after":0,"derivative":{"exercise_price":109.392,"expiration_date":"2019-05-30","underlying":"Common Stock, $.01 Par Value","underlying_shares":3298},"source":{"system":"sec-edgar","filing":"0001225208-19-008744","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000122520819008744/doc4.xml","form_type":"4"}},{"id":3505315,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-06-03T18:23:37.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":320,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6819,"source":{"system":"sec-edgar","filing":"0001225208-19-008744","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000122520819008744/doc4.xml","form_type":"4"}},{"id":3505314,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-06-03T18:23:37.000Z","date":"2019-05-30","kind":"tax_withholding","acquired":false,"shares":2438,"price":147.99,"value":360799.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares tendered to Company to cover payment of exercise price due upon exercise of stock options."}],"balance_after":6499,"source":{"system":"sec-edgar","filing":"0001225208-19-008744","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000122520819008744/doc4.xml","form_type":"4"}},{"id":3505313,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-06-03T18:23:37.000Z","date":"2019-05-30","kind":"exercise","acquired":true,"shares":3298,"price":109.392,"value":360774.816,"ownership":{"direct":true},"balance_after":8937,"source":{"system":"sec-edgar","filing":"0001225208-19-008744","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000122520819008744/doc4.xml","form_type":"4"}},{"id":3522114,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-17T23:23:34.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":946,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13252,"source":{"system":"sec-edgar","filing":"0000927066-19-000074","document":"wf-form4_155813539909483.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/927066/000092706619000074/wf-form4_155813539909483.xml","form_type":"4"}},{"id":3566227,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-04T00:29:58.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":437,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12306,"source":{"system":"sec-edgar","filing":"0000927066-19-000041","document":"wf-form4_155433778144560.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/927066/000092706619000041/wf-form4_155433778144560.xml","form_type":"4"}},{"id":3620176,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-03-04T18:39:01.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":272,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5639,"source":{"system":"sec-edgar","filing":"0001225208-19-004408","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000122520819004408/doc4.xml","form_type":"4"}},{"id":3668880,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 Par Value","published_at":"2019-02-08T17:56:54.000Z","date":"2018-12-21","kind":"grant","acquired":true,"shares":201,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5367,"source":{"system":"sec-edgar","filing":"0001567619-19-002851","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000156761919002851/doc1.xml","form_type":"4/A","original_submission_date":"2018-12-26"}},{"id":3668879,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 Par Value","published_at":"2019-02-08T17:56:54.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":5166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents 1,866 shares of Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\") and 3,300 Deferred Stock Units of New Cigna acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna. In the Merger, each share of Express Scripts common stock, par value $0.01 per share (\"ESRX Common Stock\"), was exchanged for (1) 0.2434 of a share, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\") and (2) the right to receive $48.75 in cash, without interest, subject to applicable withholding taxes.  Pursuant to the Merger Agreement, upon closing of the Merger, each Express Scripts deferred stock unit was converted into a deferred stock unit relating to the common stock of New Cigna in accordance with the equity award exchange ratio set forth in the merger agreement."},{"field":"shares","element":"transactionShares","label":"F3","text":"Prior to the Merger, the reporting person held Express Scripts common stock, restricted stock units and deferred stock units.  Each restricted stock unit was converted into a right to receive a cash payment in accordance with the payment ratio set forth in the Merger Agreement and each deferred stock unit was converted into a deferred stock unit relating to the common stock of New Cigna in accordance with the equity award exchange ratio set forth in the Merger Agreement.  The Form 4 filed December 26, 2018 inadvertently included the conversion of those restricted stock units and deferred stock units into shares of New Cigna Common Stock based on the merger consideration exchange ratio.  This amendment is being filed to correct that administrative error."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents 1,866 shares of Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\") and 3,300 Deferred Stock Units of New Cigna acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna. In the Merger, each share of Express Scripts common stock, par value $0.01 per share (\"ESRX Common Stock\"), was exchanged for (1) 0.2434 of a share, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\") and (2) the right to receive $48.75 in cash, without interest, subject to applicable withholding taxes.  Pursuant to the Merger Agreement, upon closing of the Merger, each Express Scripts deferred stock unit was converted into a deferred stock unit relating to the common stock of New Cigna in accordance with the equity award exchange ratio set forth in the merger agreement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Prior to the Merger, the reporting person held Express Scripts common stock, restricted stock units and deferred stock units.  Each restricted stock unit was converted into a right to receive a cash payment in accordance with the payment ratio set forth in the Merger Agreement and each deferred stock unit was converted into a deferred stock unit relating to the common stock of New Cigna in accordance with the equity award exchange ratio set forth in the Merger Agreement.  The Form 4 filed December 26, 2018 inadvertently included the conversion of those restricted stock units and deferred stock units into shares of New Cigna Common Stock based on the merger consideration exchange ratio.  This amendment is being filed to correct that administrative error."}],"balance_after":5166,"source":{"system":"sec-edgar","filing":"0001567619-19-002851","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000156761919002851/doc1.xml","form_type":"4/A","original_submission_date":"2018-12-26"}},{"id":3710418,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-04T00:13:55.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":462,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11869,"source":{"system":"sec-edgar","filing":"0000927066-19-000012","document":"wf-form4_154656081579852.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/927066/000092706619000012/wf-form4_154656081579852.xml","form_type":"4"}},{"id":3719891,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-26T19:20:08.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":3844,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\") acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Express Scripts common stock, par value $0.01 per share (\"ESRX Common Stock\"), was exchanged for (1) 0.2434 of a share, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\") and (2) the right to receive $48.75 in cash, without interest, subject to applicable withholding taxes.  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":3844,"derivative":{"exercise_price":126.3224,"expiration_date":"2027-05-11","underlying":"Common Stock, $0.01 Par Value","underlying_shares":3844},"source":{"system":"sec-edgar","filing":"0001567619-18-008711","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000156761918008711/doc1.xml","form_type":"4"}},{"id":3719890,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-26T19:20:08.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":3376,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\") acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Express Scripts common stock, par value $0.01 per share (\"ESRX Common Stock\"), was exchanged for (1) 0.2434 of a share, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\") and (2) the right to receive $48.75 in cash, without interest, subject to applicable withholding taxes.  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":3376,"derivative":{"exercise_price":151.4786,"expiration_date":"2026-05-04","underlying":"Common Stock, $0.01 Par Value","underlying_shares":3376},"source":{"system":"sec-edgar","filing":"0001567619-18-008711","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000156761918008711/doc1.xml","form_type":"4"}},{"id":3719889,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-26T19:20:08.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":2691,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\") acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Express Scripts common stock, par value $0.01 per share (\"ESRX Common Stock\"), was exchanged for (1) 0.2434 of a share, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\") and (2) the right to receive $48.75 in cash, without interest, subject to applicable withholding taxes.  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":2691,"derivative":{"exercise_price":175.0938,"expiration_date":"2025-05-06","underlying":"Common Stock, $0.01 Par Value","underlying_shares":2691},"source":{"system":"sec-edgar","filing":"0001567619-18-008711","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000156761918008711/doc1.xml","form_type":"4"}},{"id":3719888,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-26T19:20:08.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":3074,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\") acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Express Scripts common stock, par value $0.01 per share (\"ESRX Common Stock\"), was exchanged for (1) 0.2434 of a share, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\") and (2) the right to receive $48.75 in cash, without interest, subject to applicable withholding taxes.  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":3074,"derivative":{"exercise_price":139.6294,"expiration_date":"2021-05-07","underlying":"Common Stock, $0.01 Par Value","underlying_shares":3074},"source":{"system":"sec-edgar","filing":"0001567619-18-008711","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000156761918008711/doc1.xml","form_type":"4"}},{"id":3719887,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-26T19:20:08.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":2819,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\") acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Express Scripts common stock, par value $0.01 per share (\"ESRX Common Stock\"), was exchanged for (1) 0.2434 of a share, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\") and (2) the right to receive $48.75 in cash, without interest, subject to applicable withholding taxes.  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":2819,"derivative":{"exercise_price":128.2383,"expiration_date":"2020-05-09","underlying":"Common Stock, $0.01 Par Value","underlying_shares":2819},"source":{"system":"sec-edgar","filing":"0001567619-18-008711","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000156761918008711/doc1.xml","form_type":"4"}},{"id":3719886,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-26T19:20:08.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":3298,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\") acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Express Scripts common stock, par value $0.01 per share (\"ESRX Common Stock\"), was exchanged for (1) 0.2434 of a share, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\") and (2) the right to receive $48.75 in cash, without interest, subject to applicable withholding taxes.  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In connection with the Merger, each stock option of Express Scripts outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option, with the same terms and conditions, to purchase the number shares of New Cigna Common Stock as determined in accordance with the terms of the Merger Agreement, with an exercise price determined in accordance with the terms of the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":3298,"derivative":{"exercise_price":109.392,"expiration_date":"2019-05-30","underlying":"Common Stock, $0.01 Par Value","underlying_shares":3298},"source":{"system":"sec-edgar","filing":"0001567619-18-008711","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000156761918008711/doc1.xml","form_type":"4"}},{"id":3719885,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 Par Value","published_at":"2018-12-26T19:20:08.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":12,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By IRA"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\") acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Express Scripts common stock, par value $0.01 per share (\"ESRX Common Stock\"), was exchanged for (1) 0.2434 of a share, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\") and (2) the right to receive $48.75 in cash, without interest, subject to applicable withholding taxes.  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\") acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Express Scripts common stock, par value $0.01 per share (\"ESRX Common Stock\"), was exchanged for (1) 0.2434 of a share, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\") and (2) the right to receive $48.75 in cash, without interest, subject to applicable withholding taxes.  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."}],"balance_after":12,"source":{"system":"sec-edgar","filing":"0001567619-18-008711","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000156761918008711/doc1.xml","form_type":"4"}},{"id":3719884,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 Par Value","published_at":"2018-12-26T19:20:08.000Z","date":"2018-12-21","kind":"grant","acquired":true,"shares":201,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4805,"source":{"system":"sec-edgar","filing":"0001567619-18-008711","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000156761918008711/doc1.xml","form_type":"4"}},{"id":3719883,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.01 Par Value","published_at":"2018-12-26T19:20:08.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":4604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\") acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Express Scripts common stock, par value $0.01 per share (\"ESRX Common Stock\"), was exchanged for (1) 0.2434 of a share, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\") and (2) the right to receive $48.75 in cash, without interest, subject to applicable withholding taxes.  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\") acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Express Scripts common stock, par value $0.01 per share (\"ESRX Common Stock\"), was exchanged for (1) 0.2434 of a share, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\") and (2) the right to receive $48.75 in cash, without interest, subject to applicable withholding taxes.  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."}],"balance_after":4604,"source":{"system":"sec-edgar","filing":"0001567619-18-008711","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000156761918008711/doc1.xml","form_type":"4"}},{"id":3722366,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2018-12-21T17:41:31.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":8006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted."}],"balance_after":0,"derivative":{"exercise_price":60.66,"expiration_date":"2027-05-11","underlying":"Express Scripts Holding Company Common Stock","underlying_shares":8006},"source":{"system":"sec-edgar","filing":"0000950138-18-000705","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000095013818000705/edgar.xml","form_type":"4"}},{"id":3722365,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2018-12-21T17:41:31.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":7032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted."}],"balance_after":0,"derivative":{"exercise_price":72.74,"expiration_date":"2026-05-04","underlying":"Express Scripts Holding Company Common Stock","underlying_shares":7032},"source":{"system":"sec-edgar","filing":"0000950138-18-000705","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000095013818000705/edgar.xml","form_type":"4"}},{"id":3722364,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2018-12-21T17:41:31.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":5604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted."}],"balance_after":0,"derivative":{"exercise_price":84.08,"expiration_date":"2025-05-06","underlying":"Express Scripts Holding Company Common Stock","underlying_shares":5604},"source":{"system":"sec-edgar","filing":"0000950138-18-000705","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000095013818000705/edgar.xml","form_type":"4"}},{"id":3722363,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2018-12-21T17:41:31.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":6402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted."}],"balance_after":0,"derivative":{"exercise_price":67.05,"expiration_date":"2021-05-07","underlying":"Express Scripts Holding Company Common Stock","underlying_shares":6402},"source":{"system":"sec-edgar","filing":"0000950138-18-000705","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000095013818000705/edgar.xml","form_type":"4"}},{"id":3722362,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2018-12-21T17:41:31.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":5872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted."}],"balance_after":0,"derivative":{"exercise_price":61.58,"expiration_date":"2020-05-09","underlying":"Express Scripts Holding Company Common Stock","underlying_shares":5872},"source":{"system":"sec-edgar","filing":"0000950138-18-000705","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000095013818000705/edgar.xml","form_type":"4"}},{"id":3722361,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2018-12-21T17:41:31.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":6870,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted."}],"balance_after":0,"derivative":{"exercise_price":52.53,"expiration_date":"2019-05-30","underlying":"Express Scripts Holding Company Common Stock","underlying_shares":6870},"source":{"system":"sec-edgar","filing":"0000950138-18-000705","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000095013818000705/edgar.xml","form_type":"4"}},{"id":3722360,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-21T17:41:31.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":52,"ownership":{"direct":false,"nature":"By IRA"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the agreement and plan of merger (\"Merger Agreement\") between the Issuer and Cigna Corporation, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc., upon closing of the merger of Halfmoon II, Inc. with and into the Issuer (the \"Merger\"), each common share of the Issuer was converted into the right to receive 0.2434 shares of Halfmoon Parent, Inc. common stock and $48.75 in cash. Each restricted stock unit was converted into a right to receive a cash payment in accordance with the payment ratio set forth in the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the agreement and plan of merger (\"Merger Agreement\") between the Issuer and Cigna Corporation, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc., upon closing of the merger of Halfmoon II, Inc. with and into the Issuer (the \"Merger\"), each common share of the Issuer was converted into the right to receive 0.2434 shares of Halfmoon Parent, Inc. common stock and $48.75 in cash. Each restricted stock unit was converted into a right to receive a cash payment in accordance with the payment ratio set forth in the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950138-18-000705","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000095013818000705/edgar.xml","form_type":"4"}},{"id":3722359,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-21T17:41:31.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":18917.674,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the agreement and plan of merger (\"Merger Agreement\") between the Issuer and Cigna Corporation, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc., upon closing of the merger of Halfmoon II, Inc. with and into the Issuer (the \"Merger\"), each common share of the Issuer was converted into the right to receive 0.2434 shares of Halfmoon Parent, Inc. common stock and $48.75 in cash. Each restricted stock unit was converted into a right to receive a cash payment in accordance with the payment ratio set forth in the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the agreement and plan of merger (\"Merger Agreement\") between the Issuer and Cigna Corporation, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc., upon closing of the merger of Halfmoon II, Inc. with and into the Issuer (the \"Merger\"), each common share of the Issuer was converted into the right to receive 0.2434 shares of Halfmoon Parent, Inc. common stock and $48.75 in cash. Each restricted stock unit was converted into a right to receive a cash payment in accordance with the payment ratio set forth in the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950138-18-000705","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000095013818000705/edgar.xml","form_type":"4"}},{"id":3802743,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-02T17:56:33.000Z","date":"2018-09-30","kind":"grant","acquired":true,"shares":332,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11407,"source":{"system":"sec-edgar","filing":"0000927066-18-000180","document":"wf-form4_153850297772157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/927066/000092706618000180/wf-form4_153850297772157.xml","form_type":"4"}},{"id":3876560,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-03T23:56:50.000Z","date":"2018-06-30","kind":"grant","acquired":true,"shares":342,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11075,"source":{"system":"sec-edgar","filing":"0000927066-18-000151","document":"wf-form4_153066219433479.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/927066/000092706618000151/wf-form4_153066219433479.xml","form_type":"4"}},{"id":3919267,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Appreciation Rights","published_at":"2018-05-24T22:52:38.000Z","date":"2018-05-22","kind":"exercise","acquired":false,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":65.08,"exercise_date":"2014-06-17","expiration_date":"2018-06-17","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0000927066-18-000114","document":"wf-form4_152720230023309.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/927066/000092706618000114/wf-form4_152720230023309.xml","form_type":"4"}},{"id":3919266,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-24T22:52:38.000Z","date":"2018-05-22","kind":"sale","acquired":false,"shares":1505,"price":68.2239,"value":102676.9695,"ownership":{"direct":true},"balance_after":10733,"source":{"system":"sec-edgar","filing":"0000927066-18-000114","document":"wf-form4_152720230023309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/927066/000092706618000114/wf-form4_152720230023309.xml","form_type":"4"}},{"id":3919265,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-24T22:52:38.000Z","date":"2018-05-22","kind":"tax_withholding","acquired":false,"shares":34495,"price":67.92,"value":2342900.4,"ownership":{"direct":true},"balance_after":12238,"source":{"system":"sec-edgar","filing":"0000927066-18-000114","document":"wf-form4_152720230023309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/927066/000092706618000114/wf-form4_152720230023309.xml","form_type":"4"}},{"id":3919264,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-24T22:52:38.000Z","date":"2018-05-22","kind":"exercise","acquired":true,"shares":36000,"price":65.08,"value":2342880.0,"ownership":{"direct":true},"balance_after":46733,"source":{"system":"sec-edgar","filing":"0000927066-18-000114","document":"wf-form4_152720230023309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/927066/000092706618000114/wf-form4_152720230023309.xml","form_type":"4"}},{"id":3929053,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Appreciation Rights","published_at":"2018-05-17T23:09:10.000Z","date":"2018-05-15","kind":"grant","acquired":true,"shares":7165,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7165,"derivative":{"exercise_price":66.29,"exercise_date":"2019-05-15","expiration_date":"2023-05-15","underlying":"Common Stock","underlying_shares":7165},"source":{"system":"sec-edgar","filing":"0000927066-18-000097","document":"wf-form4_152659848716156.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/927066/000092706618000097/wf-form4_152659848716156.xml","form_type":"4"}},{"id":3935417,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-14T18:16:24.000Z","date":"2018-05-10","kind":"grant","acquired":true,"shares":2818,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Grant of restricted stock units pursuant to Express Scripts Holding Company 2016 Long-Term Incentive Plan. Awards vest in three equal installments on May 1, 2019, May 1, 2020, and May 1, 2021."}],"balance_after":18917.674,"source":{"system":"sec-edgar","filing":"0000950138-18-000387","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000095013818000387/edgar.xml","form_type":"4"}},{"id":3974484,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-04T01:53:50.000Z","date":"2018-03-31","kind":"grant","acquired":true,"shares":360,"price":65.94,"value":23738.4,"ownership":{"direct":true},"balance_after":10733,"source":{"system":"sec-edgar","filing":"0000927066-18-000044","document":"wf-form4_152280681698162.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/927066/000092706618000044/wf-form4_152280681698162.xml","form_type":"4"}},{"id":4114112,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-04T00:53:48.000Z","date":"2017-12-31","kind":"grant","acquired":true,"shares":329,"price":72.25,"value":23770.25,"ownership":{"direct":true},"balance_after":10373,"source":{"system":"sec-edgar","filing":"0000927066-18-000019","document":"wf-form4_151502721445293.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/927066/000092706618000019/wf-form4_151502721445293.xml","form_type":"4"}},{"id":4195865,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-03T16:25:00.000Z","date":"2017-09-30","kind":"grant","acquired":true,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10044,"source":{"system":"sec-edgar","filing":"0000927066-17-000074","document":"wf-form4_150704788564555.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/927066/000092706617000074/wf-form4_150704788564555.xml","form_type":"4"}},{"id":4265628,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-05T23:46:17.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":367,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9644,"source":{"system":"sec-edgar","filing":"0000927066-17-000045","document":"wf-form4_149929836302787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/927066/000092706617000045/wf-form4_149929836302787.xml","form_type":"4"}},{"id":4276472,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Appreciation Rights","published_at":"2017-06-20T22:30:24.000Z","date":"2017-06-16","kind":"grant","acquired":true,"shares":7178,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7178,"derivative":{"exercise_price":13.234,"exercise_date":"2018-06-16","expiration_date":"2022-06-16","underlying":"Common Stock","underlying_shares":7178},"source":{"system":"sec-edgar","filing":"0000927066-17-000018","document":"wf-form4_149799780957392.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/927066/000092706617000018/wf-form4_149799780957392.xml","form_type":"4"}},{"id":4321349,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right-to-Buy)","published_at":"2017-05-15T16:58:10.000Z","date":"2017-05-11","kind":"grant","acquired":true,"shares":8006,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Grant of stock option pursuant to Express Scripts Holding Company 2016 Long-Term Incentive Plan. Vests in three equal installments on May 1, 2018, May 1, 2019, and May 1, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of stock option pursuant to Express Scripts Holding Company 2016 Long-Term Incentive Plan. Vests in three equal installments on May 1, 2018, May 1, 2019, and May 1, 2020."}],"balance_after":8006,"derivative":{"exercise_price":60.66,"expiration_date":"2027-05-11","underlying":"Express Scripts Holding Company Common Stock","underlying_shares":8006},"source":{"system":"sec-edgar","filing":"0000950138-17-000433","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000095013817000433/edgar.xml","form_type":"4"}},{"id":4321348,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-15T16:58:10.000Z","date":"2017-05-11","kind":"grant","acquired":true,"shares":1648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Grant of restricted stock units pursuant to Express Scripts Holding Company 2016 Long-Term Incentive Plan. Awards vest in three equal installments on May 1, 2018, May 1, 2019, and May 1, 2020."}],"balance_after":16099.674,"source":{"system":"sec-edgar","filing":"0000950138-17-000433","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087960/000095013817000433/edgar.xml","form_type":"4"}},{"id":4330684,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Appreciation Rights","published_at":"2017-05-08T18:55:38.000Z","date":"2017-05-04","kind":"exercise","acquired":true,"shares":36000,"price":42.465,"value":1528740.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Appreciation Rights were granted on 6/11/2012, and vested 100% on 6/11/2013."}],"balance_after":0,"derivative":{"exercise_price":42.465,"exercise_date":"2013-06-11","expiration_date":"2017-06-11","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001179110-17-006795","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/927066/000117911017006795/edgar.xml","form_type":"4"}},{"id":4330683,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-08T18:55:38.000Z","date":"2017-05-04","kind":"sale","acquired":false,"shares":12994,"price":65.8879,"value":856147.3726,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sale price of $65.8879. The range of prices for the sale of these shares was $65.6600 - $66.2800 rounded to the nearest thousandths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":9277,"source":{"system":"sec-edgar","filing":"0001179110-17-006795","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/927066/000117911017006795/edgar.xml","form_type":"4"}},{"id":4330682,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-08T18:55:38.000Z","date":"2017-05-04","kind":"tax_withholding","acquired":false,"shares":23006,"price":66.45,"value":1528748.7,"ownership":{"direct":true},"balance_after":22271,"source":{"system":"sec-edgar","filing":"0001179110-17-006795","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/927066/000117911017006795/edgar.xml","form_type":"4"}},{"id":4330681,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-08T18:55:38.000Z","date":"2017-05-04","kind":"exercise","acquired":true,"shares":36000,"price":42.465,"value":1528740.0,"ownership":{"direct":true},"balance_after":45277,"source":{"system":"sec-edgar","filing":"0001179110-17-006795","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/927066/000117911017006795/edgar.xml","form_type":"4"}},{"id":4362720,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-04T22:44:37.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":349,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9277,"source":{"system":"sec-edgar","filing":"0001179110-17-005689","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/927066/000117911017005689/edgar.xml","form_type":"4"}},{"id":4504412,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-05T00:05:00.000Z","date":"2016-12-31","kind":"grant","acquired":true,"shares":370,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8928,"source":{"system":"sec-edgar","filing":"0001179110-17-000370","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/927066/000117911017000370/edgar.xml","form_type":"4"}},{"id":4588165,"issuer":{"id":3482,"kind":"organization","name":"DAVITA INC.","symbol":"DVA"},"owners":[{"id":142041,"kind":"person","name":"ROPER WILLIAM L","position":1,"cik":"0001087960","reported_name":"ROPER WILLIAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-05T00:43:10.000Z","date":"2016-09-30","kind":"grant","acquired":true,"shares":359,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8558,"source":{"system":"sec-edgar","filing":"0001179110-16-030403","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/927066/000117911016030403/edgar.xml","form_type":"4"}}]}